Ghost Tree Capital’s Loxo Oncology, Inc LOXO Stock Holding History

Ghost Tree Capital’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-175,000	Closed	-$2.18M	–	92
2015 Q1	$2.18M	Buy	+175,000	New	+$2.18M	0.78%	52

Other funds holding LOXO

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Ghost Tree Capital's LOXO Position: Q2 2015 in Review

Ghost Tree Capital sold out of Loxo Oncology, Inc (LOXO) in Q2 2015, closing a stake of 175,000 shares — an estimated $2.18M sold.

Ghost Tree Capital first reported a position in LOXO in Q1 2015 and held it in 1 quarter. The position peaked at $2.18M in Q1 2015. 50 funds tracked by Wall St. Rank hold LOXO as of Q2 2015.

Ghost Tree Capital reported no remaining Loxo Oncology, Inc position as of Q2 2015 after selling out during the quarter.
Ghost Tree Capital sold 175,000 Loxo Oncology, Inc shares in Q2 2015, an estimated $2.18M.
Ghost Tree Capital first reported a position in Loxo Oncology, Inc in Q1 2015 and held it in 1 quarter.
Ghost Tree Capital's Loxo Oncology, Inc position peaked at $2.18M in Q1 2015.
50 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q2 2015.

Based on Ghost Tree Capital's 13F filing for Q2 2015, filed 14 Aug 2015.